Helminth-induced Immunomodulation Therapy (HINT)

· University of Wisconsin, Madison

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Helminth-induced Immunomodulation Therapy (HINT), covering 2019-02-06 to 2019-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis [Phase 1]